Medical Devices
Page 1 • 12 itemsGain critical insights into global medical device regulatory pathways, market trends, and innovation impacting pharmaceutical R&D and commercialization.
Everads Therapy Publishes First-in-Human Clinical Data for Suprachoroidal Injector in Ophthalmology Science
Everads Therapy reports favorable safety and tolerability data for its novel suprachoroidal drug delivery device in first-in-human trial published in peer-reviewed journal.
Edwards Lifesciences RESILIA Tissue Shows 10-Year Durability in Pivotal Aortic Valve Trial
Edwards Lifesciences announces 10-year COMMENCE trial results demonstrating long-term durability of RESILIA tissue for aortic valve replacement procedures.
Cairn Surgical's Breast Cancer Locator System Meets Primary Endpoint in Pivotal Trial, Reduces Positive Margin Rates
Cairn Surgical announces positive pivotal trial results for its Breast Cancer Locator System, showing reduced positive margin rates compared to conventional wire localization.
ZETA SURGICAL Receives FDA 510(k) Clearance for Brain Surgery Navigation System
ZETA SURGICAL's Zeta Navigation System receives FDA 510(k) clearance for brain tumor biopsies, hydrocephalus treatment, and trigeminal neuralgia procedures.
Cordis Launches SELUTION SLR Drug-Eluting Balloon in Japan for Peripheral Artery Disease Treatment
Cordis introduces SELUTION SLR PTA Drug-Eluting Balloon in Japan, offering new treatment option for peripheral artery disease patients with proven clinical outcomes.
Vensica Medical Receives FDA IND Approval for Phase 2 Trial of ViXe Needle-Free Xeomin Delivery System
Vensica Medical gets FDA clearance to begin Phase 2 trials for ViXe, a needle-free delivery system for Xeomin treatment of overactive bladder syndrome.
Concept Medical Presents 3-Year SIRONA Trial Data at Charing Cross Symposium 2026
Concept Medical Inc. announced preliminary 3-year SIRONA trial results at CX Symposium 2026, strengthening its position in peripheral drug-delivery technologies.
Cordis Launches SELUTION SLR Drug-Eluting Balloon in Japan for Peripheral Artery Disease Treatment
Cordis launches SELUTION SLR PTA Drug-Eluting Balloon in Japan, the first sirolimus-eluting balloon approved for peripheral artery disease treatment.
Boston Scientific FARAPULSE and WATCHMAN Show Positive Safety Data at Heart Rhythm 2026
Boston Scientific presents positive clinical trial data for FARAPULSE Pulsed Field Ablation and WATCHMAN devices at Heart Rhythm 2026 conference.
Adagio Medical's vCLAS Ventricular Ablation System Shows 84% Success Rate in Pivotal Trial for Heart Arrhythmia Treatment
Adagio Medical's vCLAS system achieved 84% freedom from shock and 59% freedom from VT recurrence in FULCRUM-VT pivotal trial, meeting primary endpoints.
Pulse Biosciences nPulse Cardiac Catheter Shows High Durability in Heart Rhythm 2026 Trial Data
Pulse Biosciences presents positive multicenter trial results for nPulse cardiac catheter system, showing sustained durability for atrial fibrillation treatment.
Abbott TactiFlex Duo Ablation Catheter Shows Positive Results for Complex AFib Treatment at Heart Rhythm Society 2026
Abbott presents positive 6-month FlexPulse IDE study results for TactiFlex Duo Ablation Catheter treating complex atrial fibrillation at Heart Rhythm Society 2026.